Nanogen (NGEN) Announces Consolidation of Point of Care Manufacturing Operations
More News related to NGEN
- Nanogen (NGEN) Reports a Q3 Loss; FY Guidance Unchanged
- Nanogen (NGEN) and The Elitech Group Announce Merger Agreement
- Nanogen (NGEN) Reports Q2 Loss of $0.07
- Nanogen (NGEN) Awarded New CDC Contract to Develop Molecular Diagnostic Test for Influenza and Avian Flu
- Nanogen (NGEN) Announces Consolidation of Point of Care Manufacturing Operations
Nanogen (Nasdaq: NGEN) announced that it was taking steps to reduce costs and improve margins of its rapid testing products by consolidating its point of care manufacturing operations. The consolidation will include the transfer of current operations in Toronto, Canada to the Company's San Diego facility and the cessation of manufacturing operations in Canada by the end of 2008.
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
